Hinge Health is a digital clinic focused on providing high-quality musculoskeletal (MSK) care through a combination of expert clinical care and advanced technology. Founded in 2014, the company aims to make pain management accessible and effective, utilizing tools like wearable sensors and computer vision to enhance traditional physical therapy. Their services are available at no cost through over 2,000 employers and health plans, positioning them as a leader in the digital health space. Hinge Health's innovative approach not only helps patients recover from pain but also aims to reduce the need for surgeries and opioid use, making it a compelling option for those seeking effective pain management solutions.
Otter.ai is a leading AI-driven meeting assistant that automates note-taking and transcription for meetings, interviews, and lectures. It integrates seamlessly with platforms like Zoom, Google Meet, and Microsoft Teams, providing real-time summaries, action items, and speaker identification. The company differentiates itself through its advanced AI capabilities, enabling users to focus on discussions rather than note-taking. With a strong presence in business, education, and sales sectors, Otter.ai has gained significant traction, empowering teams to enhance productivity and collaboration. Its innovative features and user-friendly interface position it as a top choice in the AI transcription market.
Vestwell is a modern savings platform that provides high-quality savings products for businesses and individuals. Their award-winning technology simplifies the complex world of savings by offering a comprehensive range of solutions, including 401(k) and 403(b) retirement plans, student loan repayment benefits, and more. With a focus on flexibility and user experience, Vestwell partners with payroll providers and financial institutions to enable scalable growth. The company has achieved significant traction, powering over 1 million savers and enabling more than 350,000 businesses, with over $30 billion in assets saved across all 50 states.
Embrace is a leader in mobile observability, providing the first and only Open Telemetry (OTel) solution specifically designed for mobile applications. Their platform empowers DevOps and SRE teams to gain crucial insights into mobile app performance, enabling them to identify and resolve user-impacting issues quickly. By integrating user-facing app data with backend performance metrics, Embrace enhances the overall user experience and drives business value. The company leverages open-source SDKs for transparent data collection, making it easier for teams to monitor and optimize mobile applications effectively. With a focus on user experience, Embrace positions itself as a vital tool for organizations looking to modernize their observability stack and improve mobile app performance.
Restor3d is a leading medical device company based in Durham, North Carolina, specializing in additive manufacturing and personalized musculoskeletal care. The company leverages advanced 3D printing technology, artificial intelligence, and biomaterials to create innovative orthopedic implants tailored to individual patient needs. Their product offerings include the Kinos Axiom® Total Ankle System and the Total Talus Replacement System, which are designed to enhance surgical outcomes and improve patient recovery. With a commitment to revolutionizing orthopedic surgery, restor3d is positioned to expand its market presence and deliver significant value to patients, surgeons, and healthcare providers.
Pryon provides a trusted, safe, and proven path to implementing generative AI in enterprises. Its best-in-class ingestion and retrieval engines can be paired with generative LLMs to implement retrieval-augmented generation, securely providing accurate, instant, and verifiable answers at enterprise scale. Created by AI pioneers behind Alexa, Siri, and Watson, Pryon is recognized for its contributions to knowledge management and is trusted by leading enterprises and government agencies. The platform reduces the distance between people and answers, enabling high-performing, resilient, and responsive organizations.
Ai Fi is the leading provider of camera-led spatial intelligence solutions, enabling businesses to create 3D digital twins of their physical spaces. Their platform optimizes store layouts, enhances customer experiences, and revolutionizes inventory management through advanced analytics and real-time data. With a focus on autonomous shopping solutions, Ai Fi has established itself as a market leader, serving a diverse clientele that includes stadiums, universities, and retail chains across 16 countries. The company is backed by strategic partners like Qualcomm Ventures and HP Tech Ventures, and is rapidly expanding its global footprint with innovative products such as Ai Fi Refresh, Ai Fi Build, and Ai Fi To-Go.
Cameo is a marketplace where fans can book personalized video shoutouts from their favourite people. Cameo's mission is to create personalized and authentic fan experiences. The company currently partner with thousands of talent across all verticals.
Howso, formerly Diveplane, is a pioneering technology company focused on advancing trustworthy AI through its Understandable AI® platform. The company aims to empower researchers, academics, and Fortune 500 companies to make informed decisions using explainable AI, which contrasts with traditional black box models. With over 60 patent assets, Howso's technology has been deployed across various sectors, including healthcare, finance, and government, enabling users to interrogate outcomes and correct biases in their data-driven decisions. The company emphasizes social impact over profits, positioning itself as a leader in responsible AI development.
Xilis is a biotechnology company focused on revolutionizing precision oncology through its Micro Organo Sphere (MOS) technology. This platform enables personalized treatment decisions by predicting patient responses and guiding optimal therapeutic options, thus transforming cancer drug development. By providing scalable patient-derived models for high-throughput drug discovery, Xilis aims to improve treatment outcomes for cancer patients and accelerate the development of novel therapeutics. The company is positioned to address the growing need for effective cancer treatments in a market where existing approaches often fail to benefit the majority of patients.
Adyn is a precision medicine company that develops personalized birth control methods. It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling users to collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception. Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC.
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine. It offers genetically engineer protein-based materials that can mimic the naturally found elastin found in extracellular tissues. The company also offers reconstructive plastic surgeries and injectable materials.